| Exscientia plc. (12/5/23). "Press Release: Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza". Oxford. |
2023-12-05 |
| IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". |
2023-12-05 |
| Refeyn Ltd.. (11/30/23). "Press Release: Refeyn Launches KaritroMP for Rapid and Reproducible Characterization of Large Viral Vectors". Oxford. |
2023-11-30 |
| Freeline Therapeutics Holdings plc. (11/22/23). "Press Release: Syncona to Acquire Freeline Therapeutics". London. |
2023-11-22 |
| Quotient Therapeutics. (11/21/23). "Press Release: Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics". Cambridge, MA. |
2023-11-21 |
| Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA. |
2023-11-21 |
| Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". |
2023-11-21 |
| Exscientia plc. (11/21/23). "Press Release: Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference". Oxford. |
2023-11-21 |
| eXmoor Pharma Concepts Ltd.. (11/16/23). "Press Release: eXmoor Appoints Matthew Paterson as First Chief Commercial Officer". Bristol. |
2023-11-16 |
| T-Therapeutics Ltd.. (11/15/23). "Press Release: T-Therapeutics Raises £48 Million Series A for Development of Next Generation TCR Therapeutics to Transform Cancer Treatment". Cambridge. |
2023-11-15 |
| Glox Therapeutics Ltd.. (11/14/23). "Press Release: Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria". Glasgow. |
2023-11-14 |
| Autifony Therapeutics Ltd.. (11/14/23). "Press Release: Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders". Stevenage. |
2023-11-14 |
| ViaNautis Bio Ltd.. (11/13/23). "Press Release: ViaNautis Bio Announces $25 Million Series A Financing to Drive the Next Generation of Genetic Nanomedicines". Cambridge. |
2023-11-13 |
| Cromatic Inc.. (11/9/23). "Press Release: Cromatic Closes $5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing". Palo Alto, CA. |
2023-11-09 |
| Valneva S.E.. (11/7/23). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint Herblain. |
2023-11-07 |
| Memo Therapeutics AG. (11/02/23). "Press Release: Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients". Schlieren. |
2023-11-02 |
| Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.. |
2023-10-31 |
| Bicycle Therapeutics plc. (10/30/23). "Press Release: Bicycle Therapeutics to Participate in Upcoming Investor Conferences". Cambridge. |
2023-10-30 |
| MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY. |
2023-10-30 |
| OrbiMed Advisors LLC. (10/24/23). "Press Release: OrbiMed Raises $4.3 Billion Across Private Investment Funds". New York, NY. |
2023-10-24 |
| Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki. |
2023-10-23 |
| GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London. |
2023-10-20 |
| bioMérieux S.A.. (10/19/23). "Press Release: bioMérieux Makes Strategic Investment in Oxford Nanopore". Oxford & Marcy-l’Etoile. |
2023-10-19 |
| Cresset Biomolecular Discovery Ltd.. (10/18/23). "Press Release: Cresset Targets International Growth with Innovate UK Scaleup Programme". Cambridge. |
2023-10-18 |
| Exscientia plc. (10/17/23). "Press Release: Parker Moss to Join Exscientia as EVP, Corporate Development". Oxford. |
2023-10-17 |
| Refeyn Ltd.. (10/17/23). "Press Release: Refeyn Expands the Analytical Possibilities for High Concentration Samples by MassFluidix HC". Oxford. |
2023-10-17 |
| Antiverse Ltd.. (10/16/23). "Press Release: Antiverse and GlobalBio, Inc. Extend Collaboration to Advance Antibody Cancer Therapeutics". Cardiff & Cambridge, MA. |
2023-10-16 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (10/10/23). "Press Release: Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration". Tokyo & Cambridge. |
2023-10-10 |
| AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London. |
2023-10-09 |
| LimmaTech Biologics AG. (10/9/23). "Press Release: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections". Schlieren. |
2023-10-09 |
| Medicines Discovery Catapult (MDC). (10/5/23). "Press Release: UK Launches Its First National Total-body PET Platform for Drug Discovery". |
2023-10-05 |
| Markes International Ltd.. (10/5/23). "Press Release: Schauenburg Analytics Ltd Announces Appointment of New CEO". |
2023-10-05 |
| EBD Group. (10/4/23). "Press Release: BIO-Europe Set to Break Records in Munich, Germany". Munich. |
2023-10-04 |
| Exscientia plc. (10/3/23). "Press Release: Exscientia Details Pipeline Prioritisation Strategy". Oxford. |
2023-10-03 |
| Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford. |
2023-10-02 |
| Mogrify Ltd.. (10/2/23). "Press Release: Mogrify Extends Series A Financing to $46 Million USD". Cambridge. |
2023-10-02 |
| Broken String Biosciences Ltd.. (10/2/23). "Press Release: Broken String Biosciences Strengthens Senior Leadership Team to Accelerate Product Development and Commercialization". Cambridge. |
2023-10-02 |
| Laverock Therapeutics Ltd.. (9/28/23). "Press Release: Laverock Therapeutics Raises £13.5M to Develop Unique Gene Silencing Platform for Programmable Advanced Therapies". |
2023-09-28 |
| Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen. |
2023-09-28 |
| BioProtect Ltd.. (9/27/23). "Press Release: BioProtect Secures $28M to Commercialize Its Biodegradable Balloon for Rectal Protection During Prostate Cancer Radiation Therapy". Tzur Igal. |
2023-09-27 |
| Cytel Inc.. (9/26/23). "Press Release: Cytel Continues Expansion of Market Access and Medical Communication Capabilities with the Acquisition of Co.faktor". Waltham, MA. |
2023-09-26 |
| Biosynth AG. (9/25/23). "Press Release: Biosynth Extends its Offering to Multi-Kilogram GMP Peptide Synthesis through the Acquisition of Pepceuticals". Staad. |
2023-09-25 |
| Argobio S.A.S.. (9/25/23). "Press Release: Northern Gritstone and Argobio Studio Back Sheffield University Spin-out Crucible Therapeutics". Paris, Manchester & Sheffield. |
2023-09-25 |
| Exscientia plc. (9/20/23). "Press Release: Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany". Oxford. |
2023-09-20 |
| Oxford Biomedica plc. (9/20/23). "Press Release: Oxford Biomedica and Institut Mérieux Enter into Exclusive Negotiations with Respect to the Proposed Acquisition by Oxford Biomedica of ABL Europe". Oxford. |
2023-09-20 |
| BenevolentAI. (9/20/23). "Press Release: BenevolentAI Signs Strategic Collaboration with Merck". London. |
2023-09-20 |
| AstraZeneca plc. (9/20/23). "Press Release: Alexion Completes Purchase and Licence Agreement for Early-stage Rare Disease Gene Therapy Portfolio from Pfizer". |
2023-09-20 |
| Bionow (The Centre of Excellence for Life Sciences Ltd. trading as Bionow). (9/20/23). "Press Release: 2023 BioCap Conference Pitching Competition Finalists Announced". |
2023-09-20 |
| Merck KGaA. (9/20/23). "Press Release: Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery [Not intended for US-, Canada- or UK-based media]". Darmstadt. |
2023-09-20 |
| Rentschler Biopharma SE. (9/19/23). "Press Release: Rentschler Biopharma Appoints Benedikt von Braunmuehl as Chief Executive Officer". Laupheim, Stevenage & Milford, MA. |
2023-09-19 |
| Galapagos N.V.. (9/19/23). "Press Release: Galapagos Appoints Simon Sturge to Its Board of Directors". Mechelen. |
2023-09-19 |
| Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. |
2023-09-18 |
| BenevolentAI. (9/18/23). "Press Release: BenevolentAI Welcomes Christina Busmalis as Its New Chief Revenue Officer". London. |
2023-09-18 |
| ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY. |
2023-09-12 |
| Kuano Ltd.. (9/12/23). "Press Release: Kuano Raises £1.8M in Seed Funding Round to Accelerate Quantum Drug Discovery". Cambridge. |
2023-09-12 |
| Bastion Therapeutics Ltd.. (9/12/23). "Press Release: Bastion Therapeutics Secures Launch Financing to Develop Advanced Treg Therapeutics". London. |
2023-09-12 |
| BenevolentAI. (9/11/23). "Press Release: Appointment of Catherine Isted, ACMA, as Chief Financial Officer". London. |
2023-09-11 |
| Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. |
2023-09-11 |
| Orbit Discovery Ltd.. (9/11/23). "Press Release: Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer". Texas & Oxford. |
2023-09-11 |
| Novartis AG. (9/11/23). "Press Release: Sandoz Announces Exclusive Deal to Commercialize Biosimilar Ustekinumab". Basel. |
2023-09-11 |
| Verge Analytics, Inc. (d/b/a Verge Genomics). (9/8/23). "Press Release: Verge Genomics Announces Artificial Intelligence-enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases". South San Francisco, CA. |
2023-09-08 |
| Corteria Pharmaceuticals S.A.S.. (9/7/23). "Press Release: Corteria Pharmaceuticals Announces a €65M ($71M) Financing to Advance Transformational Medicines in Cardiovascular Diseases". Paris. |
2023-09-07 |
| inContAlert GmbH. (9/6/23). "Press Release: Disruption in the Field of Incontinence. MedTech Startup inContAlert Raises EUR 1.5 Million". |
2023-09-06 |
| Optibrium Ltd.. (8/31/23). "Press Release: Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering". Cambridge. |
2023-08-31 |
| Theragenix Ltd.. (8/31/23). "Press Release: Theragenix and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration". London & Nottingham. |
2023-08-31 |
| Exscientia plc. (8/31/23). "Press Release: Exscientia to Present at Upcoming Investor Conferences in September". Oxford. |
2023-08-31 |
| Intellegens Ltd.. (8/30/23). "Press Release: Intellegens and CPI Awarded £1.6m Innovate UK Grant to Advance Manufacture of Oligonucleotide Therapeutics with Machine Learning". Cambridge. |
2023-08-30 |
| CEPI. (8/29/23). "Press Release: CEPI and University of Oxford to Accelerate Vaccine Development against Disease X". Oslo & Oxford. |
2023-08-29 |
| Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC. |
2023-08-28 |
| Synthego Corporation. (8/24/23). "Press Release: Synthego and bit.bio Expand Strategic Partnership to Build a Platform for the Development of Safer and More Efficient Genetic Engineering of Human Cells for Cell Therapies". Redwood City, CA & Cambridge. |
2023-08-24 |
| Rentschler Biopharma SE. (8/23/23). "Press Release: Collaboration to Improve Process Analytical Technologies and AAV Manufacturing for Gene Therapies". Stevenage, London & Laupheim. |
2023-08-23 |
| Mysthera Therapeutics AG. (8/21/23). "Press Release: Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies". Basel. |
2023-08-21 |
| Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". |
2023-08-21 |
| Lindus Health Ltd.. (8/16/23). "Press Release: Announcing Our $18m Series A Led by Investors Creandum and with Participation from Peter Thiel". London. |
2023-08-16 |
| Refeyn Ltd.. (8/15/23). "Press Release: Refeyn Expands into AAV-based Gene Therapy Manufacturing with GMP Software". Oxford. |
2023-08-15 |
| Temedica GmbH. (8/2/23). "Press Release: Temedica and AbbVie Germany Are Launching Digital Companion for Patients with Chronic Inflammatory Bowel Diseases". |
2023-08-02 |
| Sygnature Discovery Ltd.. (7/31/23). "Press Release: Sygnature Discovery Accelerates Global Growth with Major North American Acquisition". |
2023-07-31 |
| NK:IO Ltd.. (7/25/23). "Press Release: NK:IO Raises £1.2M, Bringing Total Seed Funding to £5.1M, to Advance Pioneering NK Cell Therapy". London. |
2023-07-25 |
| Crescendo Biologics Ltd.. (7/24/23). "Press Release: Crescendo Biologics Secures $32m and Announces Expansion of CB307 Phase 1b Trial in PSMA+ Solid Tumours". Cambridge. |
2023-07-24 |
| Molecure S.A.. (7/21/23). "Press Release: Molecure Completes Successful Secondary Public Offering (SPO) of approximately PLN 50 Million (USD 12 Million)". Warsaw. |
2023-07-21 |
| Idorsia Ltd.. (7/20/23). "Press Release: Idorsia Sells Its Asia Pacific (ex-China) Operations – Including Select License Rights to Products – to Sosei Heptares for a Total Consideration of CHF 400 Million". Allschwil. |
2023-07-20 |
| LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren. |
2023-07-20 |
| BioGeneration Ventures B.V.. (7/19/23). "Press Release: Dr. Markus Kalousek and Dr. Andrew Lightfoot Join BGV as Venture Partners". Amsterdam. |
2023-07-19 |
| Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford. |
2023-07-19 |
| Pieris Pharmaceuticals, Inc.. (7/18/23). "Press Release: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring". Boston, MA. |
2023-07-18 |
| Bicycle Therapeutics plc. (7/18/23). "Press Release: Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridg |
2023-07-18 |
| Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA. |
2023-07-18 |
| Flagship Pioneering. (7/18/23). "Press Release: Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs". Cambridge, MA & New York, NY. |
2023-07-18 |
| Saniona AB. (7/17/23). "Press Release: Saniona Enters into Collaboration Agreement with AstronauTx in Alzheimer’s Disease". |
2023-07-17 |
| Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. |
2023-07-12 |
| Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-based Therapeutics and In Vivo Reprogramming". London. |
2023-07-12 |
| SparingVision S.A.S.. (7/12/23). "Press Release: SparingVision Sells Ex Vivo GIRK Technology to Tenpoint Therapeutics". Paris. |
2023-07-12 |
| Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. |
2023-07-12 |
| Ramarketing & PR Ltd.. (7/11/23). "Press Release: Ramarketing Announces North American Expansion". |
2023-07-11 |
| NK:IO Ltd.. (7/11/23). "Press Release: Imperial Spinout NK:IO Awarded £1.6M Innovate UK New Cancer Therapeutics Grant for Development of Pioneering NK Cell Therapy". London. |
2023-07-11 |
| Golgi Neurosciences S.r.l.. (7/5/23). "Press Release: Golgi Neurosciences, a Unique Incubator to Combat Neurodegenerative Disorders, Starts Operating". Milan. |
2023-07-05 |
| Camena Bioscience Ltd.. (7/3/23). "Press Release: Camena Bioscience Close $10 Series A Financing as Demand for DNA Synthesis Technology Increases". |
2023-07-03 |
| Novacyt S.A.. (7/3/23). "Press Release: Recommended Cash Offer. Novacyt UK Holdings Limited (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc [ RESTRICTED]". |
2023-07-03 |
| Astraveus S.A.S.. (6/27/23). "Press Release: Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of Its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform". Paris. |
2023-06-27 |
| EBD Group. (6/27/23). "Press Release: BIO-Europe 2024 Is Going to Stockholm". Munich. |
2023-06-27 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
